Literature DB >> 12949810

Radiation-related mortality among offspring of atomic bomb survivors: a half-century of follow-up.

Shizue Izumi1, Akihiko Suyama, Kojiro Koyama.   

Abstract

Our objective was to examine whether parental exposure to atomic bomb radiation has led to increased cancer and/or noncancer mortality rates among the offspring. We studied 41,010 subjects born from May 1946 through December 1984 (i.e., conceived between 1 month and 38 years after the bombings) and surviving for at least 1 year. One or both parents were in Hiroshima or Nagasaki at the time of the bombings and childbirth. We analyzed mortality data from 1946 to 1999 using the Japanese family registry system by Cox regression model and examined the effects of paternal and maternal irradiation with adjustment for city, sex, year of birth and parental age at childbirth. During follow-up, 314 cancer deaths and 1,125 noncancer disease deaths occurred. The mean age of living subjects was 45.7 years. Median doses were 143 mSv for 12,722 exposed fathers and 132 mSv for 7,726 exposed mothers. Cancer and noncancer mortality rates were no higher for subjects with exposed parents (5+ mSv or unknown dose) than for reference subjects (0-4 mSv), and mortality did not increase with increasing dose. For subjects with both parents exposed, the adjusted hazard ratios were 1.16 [95% confidence interval (CI) 0.92-1.46] for noncancer and 0.96 (95% CI 0.59-1.55) for cancer. This was true of deaths occurring both before and after 20 years of age. However, because of uncertainty due to the small number of deaths and relatively young ages of subjects, we cannot rule out an increase in disease mortality at this time. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12949810     DOI: 10.1002/ijc.11400

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Genetic disease in the children of Danish survivors of childhood and adolescent cancer.

Authors:  Jeanette F Winther; Jørgen H Olsen; Huiyun Wu; Yu Shyr; John J Mulvihill; Marilyn Stovall; Annelise Nielsen; Marianne Schmiegelow; John D Boice
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

2.  Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki.

Authors:  Evan B Douple; Kiyohiko Mabuchi; Harry M Cullings; Dale L Preston; Kazunori Kodama; Yukiko Shimizu; Saeko Fujiwara; Roy E Shore
Journal:  Disaster Med Public Health Prep       Date:  2011-03       Impact factor: 1.385

3.  The Likelihood of Adverse Pregnancy Outcomes and Genetic Disease (Transgenerational Effects) from Exposure to Radioactive Fallout from the 1945 Trinity Atomic Bomb Test.

Authors:  John D Boice
Journal:  Health Phys       Date:  2020-10       Impact factor: 2.922

4.  Cancer incidence in children and young adults did not increase relative to parental exposure to atomic bombs.

Authors:  S Izumi; K Koyama; M Soda; A Suyama
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

5.  Childhood cancer in the offspring born in 1921-1984 to US radiologic technologists.

Authors:  K J Johnson; B H Alexander; M M Doody; A J Sigurdson; M S Linet; L G Spector; W Hoffbeck; S L Simon; R M Weinstock; J A Ross
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640

6.  Epidemiological research on radiation-induced cancer in atomic bomb survivors.

Authors:  Kotaro Ozasa
Journal:  J Radiat Res       Date:  2016-03-13       Impact factor: 2.724

7.  Japanese Legacy Cohorts: The Life Span Study Atomic Bomb Survivor Cohort and Survivors' Offspring.

Authors:  Kotaro Ozasa; Eric J Grant; Kazunori Kodama
Journal:  J Epidemiol       Date:  2018-03-17       Impact factor: 3.211

8.  A case-control study in Hiroshima and Nagasaki examining non-radiation risk factors for thyroid cancer.

Authors:  Jun Nagano; Kiyohiko Mabuchi; Yasuhiko Yoshimoto; Yuzo Hayashi; Nobuo Tsuda; Charles Land; Kazunori Kodama
Journal:  J Epidemiol       Date:  2007-05       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.